Sana Biotechnology, Inc. (SANA) Misses Q4 EPS by 7c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q4 EPS of ($0.21), $0.07 worse than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Kura Oncology (KURA) Tops Q2 EPS by 11c, Beats on Revenue
• WhiteFiber strikes deal with Krambu for 100MW GPU capacity in 2027
• Fermi names Lee McIntire as CEO, effective August 11